At StratifAI, we develop multimodal artificial intelligence models that deliver meaningful prognostic insights from routinely available histology images and clinical data to guide treatment decisions in oncology.
We created the most comprehensive breast cancer prognostication AI test, capable of assessing adjuvant chemotherapy benefit directly from routinely available hematoxylin & eosin-stained whole-slide images. This test helps reduce unnecessary overtreatment of breast cancer patients, lowers costs, and delivers rapid results compared to traditional genomic assays.
*Available for research use only
Building on years of research, we’ve developed a suite of AI tools that identify biomarkers from routinely available data. Our adaptable platform offers customizable solutions to meet the unique needs of biopharma partners.
*Available for research use only
We push the boundaries of precision oncology through artificial intelligence. Spinning off from two leading universities, we have pioneered AI-based precision oncology and multimodal AI.
Discovering new biomarkers for precision medicine to advance the fight against cancer.
Improving patient care with personalized treatment recommendations and data-driven guidance for optimized management and outcomes.
Enhance individual treatment planning through precise prognostic models.
Assist in deciding whether adjuvant chemotherapy is necessary.
Enable faster treatment decisions with our fully digital workflow, providing same-day results.
Treatment plans that are tailored to your specific need for a more effective fight against cancer in your body
Accelerated diagnosis so that treatment can start sooner leading to better outcomes
Minimize side effects and burden from chemotherapy that might not be necessary
Identify new biomarkers for the development of targeted therapies.
Improve patient selection and monitoring through reliable AI-driven analyses.
Harness spatial data from the tumor microenvironment to enrich your R&D processes
Lower healthcare costs by avoiding unnecessary and expensive treatments
Better risk and cost estimation with precise prognostic models
Optimize healthcare resources by identifying high-risk patients and allocating treatments effectively
Enhance individual treatment planning through precise prognostic models.
Assist in deciding whether adjuvant chemotherapy is necessary.
Enable faster treatment decisions with our fully digital workflow, providing same-day results.
Treatment plans that are tailored to your specific need for a more effective fight against cancer in your body
Accelerated diagnosis so that treatment can start sooner leading to better outcomes
Minimize side effects and burden from chemotherapy that might not be necessary
Identify new biomarkers for the development of targeted therapies.
Improve patient selection and monitoring through reliable AI-driven analyses.
Harness spatial data from the tumor microenvironment to enrich your R&D processes
Lower healthcare costs by avoiding unnecessary and expensive treatments
Better risk and cost estimation with precise prognostic models
Optimize healthcare resources by identifying high-risk patients and allocating treatments effectively
